Outcomes of treating hypertension in the elderly: A short commentary on current issues

American Journal of Geriatric Cardiology

Volumn 12, Issue 1, 2003, Pages 14-18

  Weber, Michael A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; LOSARTAN; PERINDOPRIL;

AGED; ARTERY COMPLIANCE; BLOOD PRESSURE REGULATION; BLOOD VESSEL COMPLIANCE; CAPACITANCE BLOOD VESSEL; CLINICAL TRIAL; CONFERENCE PAPER; DEMENTIA; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERTENSION; OBESITY; PATHOPHYSIOLOGY; PULSE PRESSURE; STROKE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0037233908     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2003.01758.x     Document Type: Conference Paper

References (27)

1. Fagard RH. Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol. 2002;11:23-28.
2. Ferrari AU. Modifications of the cardiovascular system with aging. Am J Geriatr Cardiol. 2002;11:30-33, 39.
3. Laurent S, Boutouyrie P, Benetos A. Pathophysiology of hypertension in the elderly. Am J Geriatr Cardiol. 2002;11:34-39.
4. Elliott WJ, Black HR. Treatment of hypertension in the elderly. Am J Geriatr Cardiol. 200;11:11-22.
5. Leonetti G, Zanchetti A. Results of antihypertensive treatment trials in the elderly. Am J Geriatr Cardiol. 2002;11:41-47.
6. Zanchetti A, Leonetti G. Treating high blood pressure in the elderly: a challenge. Am J Geriatr Cardiol. 2002;11:10.
7. Wenger NK, Scheidt S, Weber MA. Hypertension at elderly age: what we know and what we must learn. Am J Geriatr Cardiol. 2002;11:8-10.
8. Schrier RW. Treating hypertension in the elderly. Am J Geriatr Cardiol. 2001;10:355-365.
9. O'Donnell CJ, Kannel WB. Epidemiologic appraisal of hypertension as a coronary risk factor in the elderly. Am J Geriatr Cardiol. 2002;11:86-92.
10. Franklin SS, Kahn SA, Wong ND, et al. Is the pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354-360.
11. Franklin SSK, Gustin WT, Wong ND. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
12. Weber MA. The measurement of arterial properties in hypertension. Am J Hypertens. 2001;14:183-185.
13. Beltram A, McVeigh G, Morgan D, et al. Arterial compliance abnormalities in isolated systolic hypertension. Am J Hypertens. 2001;14:1007-1011.
14. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
15. Staessen JA, Fagard R, Thijs L, et al., for the Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
16. Curb JD, Pressel SL, Cutler JA, et al., for the Systolic Hypertension in the Elderly Cooperative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA. 1996;276:1886-1892.
17. Tumilehto J, Rastenyte D, Birkenhager WH, et al., for the Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med. 1999;340:677-684.
18. Forette F, Seux ML, Staessen JA, et al., on behalf of the SYST-EUR Investigators. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (SYST-EUR) trial. Lancet. 1998;352:1347-1351.
19. Barrett-Connor E, Khaw K. Is hypertension more benign when associated with obesity? Circulation. 1985;72:53-60.
20. Weber MA, Neutel JM, Smith DHG. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol. 2001;37:169-174.
21. Wassertheil-Smoller S, Fann C, Allman RM, et al. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. Arch Intern Med. 2000;160:494-500.
22. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50:272-298.
23. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet. 2000;355:1955-1964.
24. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet. 2000;356:1949-1954.
25. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359:995-1003.
26. PROGRESS Collaborative Group. Randomized trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.
27. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensinconverting enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145-153.